Isoniazid preventive therapy during infancy does not adversely affect growth among HIV-exposed uninfected children: Secondary analysis of data from a randomized controlled trial
IPT administered to HEU infants did not significantly impact growth outcomes in the first two years of life.
Authors
- Jerphason Mecha (ORCID: https://orcid.org/0009-0008-6446-0395)
- Ashenafi S. Cherkos (ORCID: https://orcid.org/0000-0002-3111-5025)
- Daniel A. Enquobahrie (ORCID: https://orcid.org/0000-0001-9844-0597)
- Jaclyn N Escudero (ORCID: https://orcid.org/0000-0002-3513-774X)
- Sylvia M. LaCourse (ORCID: https://orcid.org/0000-0002-9809-5997)
- Sarah Iribarren (ORCID: https://orcid.org/0000-0003-2980-0717)
- Grace C. John-Stewart (ORCID: https://orcid.org/0000-0002-4301-1573)
- John Kinuthia (ORCID: https://orcid.org/0000-0001-6571-8927)
- Daniel Matemo (ORCID: https://orcid.org/0000-0002-7209-1648)
Institutions
- University of North Texas (US)
- University of North Texas Health Science Center (US)
- University of Washington (US)
- Kenyatta National Hospital (KE)
- Kenya Medical Research Institute (KE)
- Neurobehavioral Systems (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1371/journal.pone.0293708
- Citations
- 1
- Primary Topic
- Child Nutrition and Water Access
- Type
- article
- Field-Weighted Citation Impact
- 0.31
Funders
- Thrasher Research Fund
- University of Washington
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- Fogarty International Center
- National Center for Advancing Translational Sciences